Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 11.05.2025 6 BMC Cancer 5 Br J Dermatol 1 Cancer 1 Clin Exp Dermatol 10 Cutis 5 Int J Dermatol 1 J Cutan Pathol 13 J Dermatol 6 J Invest Dermatol 1 Mycoses 2 PLoS Comput Biol 1 PLoS Med 13 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. KANG Y, Han B, Kong Y, Liu S, et al
   Efficacy and safety of first-line CDK4/6 inhibitors plus AI therapy for patients with HR +/HER2- advanced breast cancer: a network meta-analysis.
   BMC Cancer. 2025;25:843.
   PubMed         Abstract available
   
   
2. DE SOUZA MAMEDE VF, Bernabe RAM, Santos TG, da Silva LL, et al
   Risk of sarcopenia in women with breast cancer: a comparative analysis of screening tools.
   BMC Cancer. 2025;25:839.
   PubMed         Abstract available
   
   
3. LIU M, Sun Z, Tan P, Xie D, et al
   Associations between psoriasis and risk of 33 cancers: a Mendelian randomization study.
   BMC Cancer. 2025;25:837.
   PubMed         Abstract available
   
   
4. AHMAD S, Zafar I, Shafiq S, Sehar L, et al
   Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis.
   BMC Cancer. 2025;25:830.
   PubMed         Abstract available
   
   
5. YANG Y, Liao T, Lin XH, Ouyang R, et al
   Dual-region MRI radiomic analysis indicates increased risk in high-risk breast lesions: bridging intratumoral and peritumoral radiomics for precision decision-making.
   BMC Cancer. 2025;25:828.
   PubMed         Abstract available
   
   
6. YILDIRIM S, Basoglu T, Dogan A, Akdag G, et al
   The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
   BMC Cancer. 2025;25:833.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

7. KIRCIK L, Tsianakas A, Valenzuela F, Mikol V, et al
   Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical Trial.
   Br J Dermatol. 2025 May 3:ljaf156. doi: 10.1093.
   PubMed         Abstract available
   
   
8. FOWLER JC, Sood RK, Coltart G, Lai C, et al
   The mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin; relevance to NB-UVB lifetime exposures and skin cancer surveillance.
   Br J Dermatol. 2025 May 3:ljaf173. doi: 10.1093.
   PubMed         Abstract available
   
   
9. MORTIMORE AM, McMeniman E
   Reassuring results from skin cancer risk in Swedish patients with vitiligo and alopecia areata.
   Br J Dermatol. 2025 May 6:ljaf118. doi: 10.1093.
   PubMed        
   
   
10. WHITEMAN DC
    Melanoma in England: incidence is up, mortality is down.
    Br J Dermatol. 2025 May 7:ljaf175. doi: 10.1093.
    PubMed        
    
    
11. DRUCKER AM, Walwyn C, Chu C, Yiu ZZN, et al
    Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.
    Br J Dermatol. 2025 May 7:ljaf166. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

12. LEE MS, Thomas SM, Louie AD, Rosenberger LH, et al
    Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.
    Cancer. 2025;131:e35891.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

13. CHEN TL, Chang YT, Chang TH
    Generalized targetoid papules with knuckle-sparing hands in a middle-aged man.
    Clin Exp Dermatol. 2025 May 8:llaf205. doi: 10.1093.
    PubMed        
    
    

    
    Cutis

14. THEKHO AJ, Ramesh V, Passi S
    Pseudoverrucous Papules and Nodules Around a Surgical Stoma.
    Cutis. 2025;115:E19-E20.
    PubMed        
    
    
15. FILLEY A, Preston A, Parekh P
    Pink Papule on the Lower Eyelid.
    Cutis. 2025;115:94-101.
    PubMed        
    
    
16. BERAJA GE, Buckley KA, Sammons DL
    A Painful Flesh-Colored Papule on the Shoulder.
    Cutis. 2025;115:E14-E16.
    PubMed        
    
    
17. OBINWANNE V, Crow LD, James AJ
    Cyclically Bleeding Umbilical Papules.
    Cutis. 2025;115:79-86.
    PubMed        
    
    
18. PARISER RJ, Alnaif S
    Analysis of Errors in the Management of Cutaneous Disorders.
    Cutis. 2025;115:E31-E36.
    PubMed         Abstract available
    
    
19. PATE HF, Hill K, McGovern TW
    Not as Bland as You May Think: Celery (Apium graveolens) Commonly Induces Phytophotodermatitis.
    Cutis. 2025;115:E28-E30.
    PubMed         Abstract available
    
    
20. WONG N, Williams K, Tolliver S, Potts G, et al
    Historical Perspectives on Hair Care and Common Styling Practices in Black Women.
    Cutis. 2025;115:95-98.
    PubMed         Abstract available
    
    
21. KUMETZ EA, Cox JA
    Managing Contact Dermatitis Related to Amputee Care.
    Cutis. 2025;115:80-82.
    PubMed         Abstract available
    
    
22. KOVACS LD, Cogen AL
    A Systematic Review of Dermatologic Findings in Adults With Hemophagocytic Lymphohistiocytosis.
    Cutis. 2025;115:87-93.
    PubMed         Abstract available
    
    
23. THOMAS KV, Choi F, Le T, McGuire M, et al
    Dupilumab in the Treatment of Pemphigoid Gestationis.
    Cutis. 2025;115:102-104.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

24. ZHAO Y, Zhang L, Wu L, Yang B, et al
    Stapokibart Rapidly and Consistently Improves the Clinical Signs Across All Body Regions in Adults With Moderate-to-Severe Atopic Dermatitis.
    Int J Dermatol. 2025 May 2. doi: 10.1111/ijd.17820.
    PubMed        
    
    
25. KASSELS AC, Arora JS, Min MS
    Evaluating Skin of Color Representation for Connective Tissue Diseases in Dermatology Textbooks.
    Int J Dermatol. 2025 May 5. doi: 10.1111/ijd.17837.
    PubMed        
    
    
26. BRANDAO MPAS, Vieira CFO, Rocha DBB, Silva MR, et al
    Outcomes of a Non-Surgical Combination Therapy for Keloids in Skin of Color Patients: A 10-Year Follow-Up Study.
    Int J Dermatol. 2025 May 5. doi: 10.1111/ijd.17829.
    PubMed         Abstract available
    
    
27. MELGOSA RAMOS FJ, Sergio Santos Alarcon S, Silvestre Salvador JF, Martorell A, et al
    A Perspective on Potential Disease Modification in Atopic Dermatitis.
    Int J Dermatol. 2025 May 5. doi: 10.1111/ijd.17835.
    PubMed        
    
    
28. VARGA NN, Gulyas L, Meznerics FA, Barkovskij-Jakobsen KS, et al
    Diagnostic Accuracy of Novel Optical Imaging Techniques for Melanoma Detection: A Systematic Review and Meta-Analysis.
    Int J Dermatol. 2025 May 7. doi: 10.1111/ijd.17828.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

29. NAITO A, Irie H, Fujimoto M, Nakamizo S, et al
    BCL-6-Positive Cutaneous Mantle Zone Hyperplasia: A Novel Subtype of B-Cell Cutaneous Lymphoid Hyperplasia.
    J Cutan Pathol. 2025 May 5. doi: 10.1111/cup.14820.
    PubMed         Abstract available
    
    

    
    J Dermatol

30. JENG YC, Liao YC, Hong YK, Cheng HC, et al
    Immunoproteomic Response to IL-17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling.
    J Dermatol. 2025 May 6. doi: 10.1111/1346-8138.17772.
    PubMed        
    
    
31. MURAYAMA Y, Shojiguchi N, Kawasaki T, Inoue S, et al
    Metastatic Cutaneous Apocrine Adenocarcinoma Successfully Treated With Nivolumab.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17777.
    PubMed        
    
    
32. TAKAYAMA E, Ijuin K, Yoshioka A
    Postherpetic Isotopic Response Manifesting as Granulomatous Dermatitis With Maculopapular Rash, Induced by Immune Checkpoint Inhibitor Use.
    J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17776.
    PubMed        
    
    
33. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    PubMed         Abstract available
    
    
34. XU Y, Yang Y, Zhan W, Zhao J, et al
    Associations of chronic kidney disease with hidradenitis suppurativa: A bidirectional Mendelian randomization study.
    J Dermatol. 2025;52:922-924.
    PubMed         Abstract available
    
    
35. MATSUO M, Zang X, Im D, Tanaka K, et al
    A case of multiple warty dyskeratomas overexpressing SERCA2 in acantholytic cells.
    J Dermatol. 2025;52:925-928.
    PubMed         Abstract available
    
    
36. HAMAGUCHI Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, et al
    Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
    J Dermatol. 2025;52:860-871.
    PubMed         Abstract available
    
    
37. KAWAMOTO H, Fujii K, Aoki M, Goto K, et al
    Ultrasound findings of endocrine mucin-producing sweat gland carcinoma mimicking epidermal cysts: A case series and diagnostic challenges.
    J Dermatol. 2025;52:939-942.
    PubMed         Abstract available
    
    
38. MATSUO M, Kato H, Kobayashi K, Nagai M, et al
    A case of pseudoangiomatous spindle-cell lipoma with unique MRI manifestations corresponding to distinct histological features.
    J Dermatol. 2025;52:943-946.
    PubMed         Abstract available
    
    
39. TANEMURA C, Nunotani M, Kawabata K, Morooka Y, et al
    Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires.
    J Dermatol. 2025;52:812-830.
    PubMed         Abstract available
    
    
40. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    PubMed         Abstract available
    
    
41. NISHIDA E, Morita A
    The required absolute PASI score to achieve DLQI remission.
    J Dermatol. 2025;52:947-949.
    PubMed         Abstract available
    
    
42. JO SJ, Kim BS, Kim DH, Kim JH, et al
    Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.
    J Dermatol. 2025;52:802-811.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

43. RECKA N, Simons A, Cornell RA, Van Otterloo E, et al
    Epidermal loss of PRMT5 leads to the emergence of an atypical basal keratinocyte-like cell population and defective skin stratification.
    J Invest Dermatol. 2025 May 6:S0022-202X(25)00449.
    PubMed         Abstract available
    
    
44. WANG J, Sun S, Guay H, Chang D, et al
    Classification of skin transcriptome reveals two molecular subtypes in hidradenitis suppurativa.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00463.
    PubMed        
    
    
45. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    PubMed        
    
    
46. MALACTOU C, Hayes M, Zhang T, Ward S, et al
    Eosinophils and bioactive lipid mediators regulate skin inflammation and cancer growth.
    J Invest Dermatol. 2025 May 2:S0022-202X(25)00461.
    PubMed         Abstract available
    
    
47. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    PubMed         Abstract available
    
    
48. ESTRACH S, Vivier CM, Tosello L, Tissot FS, et al
    Epithelial Fibronectin meshwork controls skin regeneration.
    J Invest Dermatol. 2025 Apr 30:S0022-202X(25)00458.
    PubMed         Abstract available
    
    

    
    Mycoses

49. SKRZYPCZAK T, Skrzypczak A, Jaworek A, Szepietowski JC, et al
    Common Disease-Difficult Understanding: Readability Analysis of Superficial Skin Fungal Infections On-Line Materials in European Languages.
    Mycoses. 2025;68:e70057.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

50. STAPLEY JN, Hamley JID, Basanez MG, Walker M, et al
    Modelling transmission thresholds and hypoendemic stability for onchocerciasis elimination.
    PLoS Comput Biol. 2025;21:e1013026.
    PubMed         Abstract available
    
    
51. NOURBAKHSH M, Zheng Y, Noor H, Chen H, et al
    Revealing cancer driver genes through integrative transcriptomic and epigenomic analyses with Moonlight.
    PLoS Comput Biol. 2025;21:e1012999.
    PubMed         Abstract available
    
    

    
    PLoS Med

52. LIN TL, Fan YH, Fan KS, Juan CK, et al
    Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-alpha, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort study.
    PLoS Med. 2025;22:e1004591.
    PubMed         Abstract available
    
    

    
    PLoS One

53. YE X, Xu T, Cao J, Li G, et al
    Knowledge, attitude, and practice toward genetic testing in breast cancer patients in China.
    PLoS One. 2025;20:e0322526.
    PubMed         Abstract available
    
    
54. VON BUBNOFF D, Schmitt C, Goldinger SM, Schadendorf D, et al
    Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab.
    PLoS One. 2025;20:e0321937.
    PubMed         Abstract available
    
    
55. WANG CC, Wang WX, Wu PY
    Oral zinc sulphate reduces the recurrence rate and provides significant therapeutic effects for viral warts: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0323051.
    PubMed         Abstract available
    
    
56. MIRZAEI Y, Huffel M, McCann S, Bannach-Brown A, et al
    Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes.
    PLoS One. 2025;20:e0322876.
    PubMed         Abstract available
    
    
57. JIANG S, Peng X, Chen Y, Dong B, et al
    Fucoxanthin ameliorates Propionibacterium acnes-induced ear inflammation in mice by modulating the IkappaBalpha/NF-kappaB signaling pathway and inhibiting NF-kappaB nuclear translocation.
    PLoS One. 2025;20:e0322950.
    PubMed         Abstract available
    
    
58. MOHAMMAD HUSSIN N, Nik Jaafar NR, Idris IB, Mohammed Nawi A, et al
    Evaluating the effects of e-health interventions on mental health outcomes in individuals with breast cancer: A systematic review.
    PLoS One. 2025;20:e0321495.
    PubMed         Abstract available
    
    
59. HUANG X, Wang L, Ma X, Liu S, et al
    Broussonetia papyrifera ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by modulating the TLR4/NF-kappaB and PI3K/AKT signaling pathways.
    PLoS One. 2025;20:e0322710.
    PubMed         Abstract available
    
    
60. RAMLI HAMID MT, Ab Mumin N, Abdul Hamid S, Mohd Ariffin N, et al
    Comparative analysis of diagnostic performance in mammography: A reader study on the impact of AI assistance.
    PLoS One. 2025;20:e0322925.
    PubMed         Abstract available
    
    
61. ONO F, Takahashi Y, Shimada S, Mizumoto S, et al
    Carbohydrate sulfotransferase 14 gene deletion induces dermatan sulfate deficiency and affects collagen structure and bowel contraction.
    PLoS One. 2025;20:e0320943.
    PubMed         Abstract available
    
    
62. YANG S, Cheng M, Zhang S, Wang H, et al
    DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation.
    PLoS One. 2025;20:e0321889.
    PubMed         Abstract available
    
    
63. PRAJOKO YW, Heriyanto DS, Dirja BT, Susanto S, et al
    High frequency of the PIK3CA H1047L mutation in Indonesian breast cancer across molecular subtypes.
    PLoS One. 2025;20:e0322154.
    PubMed         Abstract available
    
    
64. DOUGLAS CM, Newell M, Goruk S, Courneya KS, et al
    Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour.
    PLoS One. 2025;20:e0322178.
    PubMed         Abstract available
    
    
65. FERREIRA LG, de Almeida SR
    IL-18 production is required for the generation of a Th1 response during experimental chromoblastomycosis.
    PLoS One. 2025;20:e0322127.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.